Patient-specific outputs
- Doctors stressed to review and analyze huge quantities of data
- Care occurs outside established institution protocols
- Burdensome process to customize EMR for specific clinical needs
77% of physicians would value interpretation assistance1
Case-based rules engine delivers patient-specific content.
Intelligent insights are unlocked – directly related to patient care decisions.
Physicians receive supportive guidance and protocol reinforcement
AlinIQ CDS allows physicians to improve their ability to interpret patient results and take targeted action.
Patient-specific outputs
Reduced variability
Easy updates as guidelines change
Existing workflows
Find out how AlinIQ CDS and the family of AlinIQ Digital Health Solutions can help your organization elevate testing and empower your clinicians with patient-specific insights that support targeted action.
AlinIQ, the suite of Digital Health Solutions from Abbott, helps you uncover intelligent insights from your laboratory data and discover greater operational productivity with existing resources.
.png)
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Receive exclusive benefits and resources when you register to access to the customer portal.
Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.